TransMedics Inc. is the world’s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation. The company was founded to address the need for more and better organs for transplantation, and is focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs throughout the health care system. The OCS Lung, OCS Heart and OCS Liver are all CE marked and FDA approved devices. *****Notice of Recruitment Fraud***** It has come to our attention that individuals who are unaffiliated with TransMedics are posing as representatives and engaging with candidates regarding fake job opportunities. These fraudsters may request payment and/or financial information from you. These opportunities are not authorized by TransMedics. Please note that our recruiting process does not include asking candidates for payments of any kind and/or financial information under any circumstances. For individuals in the United States, the following link may be useful in protecting yourself: https://consumer.ftc.gov/articles/job-scams. Please note that TransMedics is not responsible for the content of this website. For individuals outside of the United States, please check with your local authorities.
External link for TransMedics, Inc.
200 Minuteman Road
Suite 302
Andover, MA 01810, US
TransMedics, Inc. reposted this
Our industry partners make the #ISHLT2024 Annual Meeting possible. Today, we recognize Pinnacle-level Supporter TransMedics, Inc. for their support of the Annual Meeting. You can see TransMedics on-site in Prague at booth 13.
Here is another real world positive impact of TransMedics’ OCS Liver and NOP to increase utilization of DCD livers for transplantation. In 2023, the US liver transplant volume grew by 12% primarily because of this impact. Again, TMDX NOP can do more to continue to drive additional growth in liver, heart and lung transplants in the US! We are grateful for donor families, our transplant centers who entrusted to procure and manage OCS perfusion for them and our world-class TMDX Team who is making this transformation a clinical reality!
It's encouraging to see non-utilization rates decreasing for hearts (left) and livers (right) from DCD donors. As far as I can tell, this is primarily driven by innovation/technology/change in practice and not by any particular policy aimed at decreasing non-utilization. As someone who thinks a lot about policy, and how policy can be crafted to achieve certain ends (e.g., decreasing non-utilization), things like this always give me pause.
The OCS Heart and NOP were used for ~70% of the DCD heart transplanted in the US in 2023, resulting in the lion’s share of the 13% growth of the national heart transplant volume in 2023! We can do more! Grateful to donor families, our clinical users and our world-class NOP clinical and logistics teams!
Finally, there is now a little bit of information around normothermic regional perfusion (NRP) in the Donation and Transplant System Explorer. NRP is not explicitly captured as a data element, so we inferred NRP if the time from declaration of death to cross clamp is longer than 30 minutes for DCD donors. Below is the trend of DCD heart transplants stratified by whether the transplant was done with or without NRP. https://lnkd.in/gBq95htt
TMDX world-class NOP clinical and aviation teams coming together to deliver precious donor organs to patients in need across the US! Keep up the great work Team TMDX!
Another dedicated hardworking OCS Team. Thank you Sadie and Taylor for all you do, offering the best transplant logistics available today. Just completed another successful mission Kentucky to California.
Congratulations to the Tufts Heart Transplant program and team for their success in growing their volumes with the help of TransMedics Heart NOP program. We are proud to be their partners and excited to continue supporting their growth in 2024. OCS NOP eliminates historical cold ischemia time and distance limitations, enabling more distant procurement of donor organs that historically were seldomly used for transplants. Thanks to the hard work of the TMDX NOP and Logistics team, we are shaping the future of organ transplantation in the US. #TransMedics #HeartNOP #Beatinghearttransplants #Heartinabox #OrganTransplantation #HealthcarePartnerships
TransMedics NOP program is expanding the reach and capabilities of transplant programs across the US to grow their transplant volumes to help patients in need. Here is our TMDX NOP Team supporting 3 organs for a major SE transplant program and another TMDX NOP Team supporting 4 organs at a major SW transplant program in the US! Shout out to our dedicated TMDX NOP teams across the US and our logistics teams who are making these cases a clinical reality every day. Keep up the GREAT work. TMDX NOP is redefining whats possible in organ transplants!
We are committed to maintaining our leadership position to develop innovative technologies to increase the number of organ transplants worldwide! Congratulations Team TMDX!